Markiewicz P J, Matthews J C, Declerck J, Herholz K
Research School of Translational Medicine, University of Manchester, Wolfson Molecular Imaging Centre, Manchester, UK.
Neuroimage. 2009 Jun;46(2):472-85. doi: 10.1016/j.neuroimage.2009.01.020.
For finite and noisy samples extraction of robust features or patterns which are representative of the population is a formidable task in which over-interpretation is not uncommon. In this work, resampling techniques have been applied to a sample of 42 FDG PET brain images of 19 healthy volunteers (HVs) and 23 Alzheimer's disease (AD) patients to assess the robustness of image features extracted through principal component analysis (PCA) and Fisher discriminant analysis (FDA). The objective of this work is to: 1) determine the relative variance described by the PCA to the population variance; 2) assess the robustness of the PCA to the population sample using the largest principal angle between PCA subspaces; 3) assess the robustness and accuracy of the FDA. Since the sample does not have histopathological data the impact of possible clinical misdiagnosis on the discrimination analysis is investigated. The PCA can describe up to 40% of the total population variability. Not more than the first three or four PCs can be regarded as robust on which a robust FDA can be build. Standard error images showed that regions close to the falx and around ventricles are less stable. Using the first three PCs, sensitivity and specificity were 90.5% and 96.9% respectively. The use of resampling techniques in the evaluation of the robustness of many multivariate image analysis methods enables researchers to avoid over-analysis when using these methods applied to many different neuroimaging studies often with small sample sizes.
对于有限且有噪声的样本,提取代表总体的稳健特征或模式是一项艰巨的任务,过度解读并不罕见。在这项工作中,重采样技术已应用于19名健康志愿者(HV)和23名阿尔茨海默病(AD)患者的42张FDG PET脑图像样本,以评估通过主成分分析(PCA)和Fisher判别分析(FDA)提取的图像特征的稳健性。这项工作的目的是:1)确定PCA描述的相对方差与总体方差;2)使用PCA子空间之间的最大主角度评估PCA对总体样本的稳健性;3)评估FDA的稳健性和准确性。由于样本没有组织病理学数据,因此研究了可能的临床误诊对判别分析的影响。PCA可以描述高达40%的总体变异性。不超过前三或四个主成分可被视为稳健的,在此基础上可以构建稳健的FDA。标准误差图像显示,靠近大脑镰和脑室周围的区域不太稳定。使用前三个主成分时,敏感性和特异性分别为90.5%和96.9%。在评估许多多元图像分析方法的稳健性时使用重采样技术,使研究人员在将这些方法应用于许多不同的、通常样本量较小的神经影像学研究时能够避免过度分析。